Ne
Neopharma
Abu Dhabi AEFounded 20031,000 employees
Private CappharmaPrivateOncology
Platform: UAE Generic
Market Cap
N/A
All Drugs
3
Clinical Trials
8
Failed / Terminated
3
FDA Approved
0
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| NEO-1964 | NEO-1964 | Phase 3 | 4 | IL-13 | Epilepsy | ||
| Fixalucimab | NEO-2390 | Preclinical | 2 | TYK2 | WilmsCRC | ||
| Ribozasiran | NEO-5380 | Phase 1/2 | 2 | C5 | EpilepsyEoE |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (8)